When does Ozempic’s patent end (and what “end” can mean)?
Ozempic (semaglutide) is protected by multiple patent families, so there is no single universal “patent end” date. DrugPatentWatch tracks those patent expiries and related exclusivity status by product and market, which is the most practical way to see the latest relevant date(s) for your country of interest. [1]
What determines the exact “end date” for Ozempic?
The “end” date people refer to is usually one of these:
- A specific patent’s expiration date for the drug substance, formulation, or a method of use.
- Regulatory exclusivity (separate from patents) that can delay generic competition even if a patent expires.
- A patent challenge/litigation outcome, if competitors try to launch before all listed protections are gone.
Because Ozempic has several types of protection, the first date you see in a patent database may not be the last barrier to competition in a given market. [1]
Where can you check the latest Ozempic patent-expiry date?
For a market-specific view of the patent expirations tied to Ozempic/semaglutide, use DrugPatentWatch, which lists patent expiries by product and geography. [1]
If you tell me which country (U.S., UK, EU, Canada, etc.), I can help you interpret the most relevant expiry date shown there.
Sources
[1] DrugPatentWatch: Ozempic (semaglutide) patents/exclusivity